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SIGNIFICANCE 
 Kalman, Morissette and George (2005), Am. J. Addict., 14: 106-123  
Arguments for Not Providing Tobacco Treatment…. 
“these patients don’t want to quit” 
“these patients will relapse (to other substances) 
if they try to quit” 
“these patients are unable to quit” 
• 80% of participants in a methadone maintenance program and 75% of participants 
     in an alcohol abuse program endorsed a desire to quit (Richter KP et al., 2001; Ellingstad TP et al, 1999)  
• In a review of 9 studies of motivation to quit smoking among individuals with  
     psychiatric disorders at least 50% are contemplating cessation (Siru, Hulse & Tait, 2009).  
• Smoking cessation efforts can ENHANCE rather than compromise 
 long term sobriety (Prochaska JJ et al, 2004). 
• Meta-analysis (n = 19 studies) of smoking cessation among individuals in 
addiction treatment and recovery found increased cessation at end of 12 weeks 
treatment (BUT NO SIGNIFICANT EFFECT AT 6 MONTHS!) (Prochaska JJ et al, 2004). 
• Recent study found end-of-treatment smoking cessation rates of 20% among 
individuals with psychiatric disorders accessing outpatient tobacco treatment 
program-Longer duration of treatment significantly predicted successful 
cessation. 
Program Description 
• The Tobacco Dependence Clinic (TDC) is a program that 
provides behavioural counselling and up to 6-7months of no-
cost pharmacotherapy for clients through VCH Addiction 
Services 
 
• Program is run with a team of nurses, counsellors, respiratory 
therapists, and a physician. 
 
• Currently in 7 Addictions services located in community 
health centres in Vancouver. 
Eligibility:  
• 19 years or older 
• Tobacco dependent 
• Have a history of substance use disorder and/or mental illness 
• Financially disadvantaged 
8-week structured group: 
 
Phase 1: engagement in the process – weeks 1-2 
 
Phase 2: planning for change – weeks 3-4 
 
Phase 3: sustaining change – weeks 5-8 
 
 
Treatment Approach 
Program philosophy: Quitting smoking is a process and not an event 
Specific Aims 
• To assess program completion and smoking cessation 
rates at end-of-treatment  
  
• To examine predictors of successful program 
completion and smoking cessation 
 
Sample for Evaluation 
678 
Intent-to-treat 
155 
Program non-completers 
523 
program completers 
• Analysis is based on a retrospective chart review of participants in the TDC 
program (between Sept 2007 and Dec, 2011) from 7 clinics, in Vancouver, Canada 
 
• Smoking cessation: 7-day point-prevalence of abstinence at end of treatment  
(i.e., anytime between 8 weeks to 26 weeks) verified by expired CO levels 
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Sample Characteristics (N = 678, 57% male) 
Mean Stand. Dev. 
Age of participant (years) 
 
48.0 11.0 
Age at smoking initiation (years) 
 
15.1 5.8 
Importance of quitting (scale of 0 ‘low’ to 10 ‘high’) 9.0 1.4 
Confidence in quitting (scale of 0 ‘low’ to 10 ‘high’) 
 
7.2 2.4 
Number of cigarettes smoked per day 
 
20.4 10.3 
Fagerstrom Test for Nicotine Dependence  
(scale of 0 ‘low’ to 10 ‘high’) 
 
6.0 2.0 
CO level at baseline (ppm) 20.9 14.2 
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0
20
40
60
80
100
Completed program?
22.9%
77.1%
Yes
No
Pe
rc
en
t %
 
Smoking Cessation* Outcomes at end-of-treatment  
*Smoking cessation at end-of-treatment (i.e., anytime between 8 weeks to 26 weeks) 
verified by expired CO levels 
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Multivariate predictorsa of program completion (n = 674) 
a. Employing a two-step model building process in which variables associated with 
smoking cessation (at alpha < 1.0) in the unadjusted analyses are included in a 
second-step for adjusted analyses. Only variables which were significantly predictive of 
smoking cessation in the final adjusted multivariate model are shown.  
 
* = p <.05, ** = p <.001, *** = p <.001 
Predictors Odds Ratio 95%CI 
Gender 
Male (referent) 
Female 
 
     1.0 
1.78** 
 
- 
1.19-2.65 
       Age 1.03** 1.01-1.05 
Hosmer-Lemeshow goodness-of-fit: χ2= 1.80 (DF=8),  p=.986 
Multivariate predictorsa of smoking cessation among 
program completers at end of treatment (n = 494) 
a. Employing a two-step model building process in which variables associated with smoking cessation (at alpha < 1.0) 
in the unadjusted analyses are included in a second-step for adjusted analyses. Only variables which were 
significantly predictive of smoking cessation in the final adjusted multivariate model are shown.  
 
* = p <.05, ** = p <.001, *** = p <.001 
Predictors Odds Ratio 95%CI 
History of Psychiatric Disorder 
None (referent) 
Mood disorder 
Anxiety disorder 
Psychotic disorder 
 
1.0 
.90 
.53* 
.69 
 
- 
.57-1.42 
.29-1.00 
.31-1.57 
FTND at baseline .89* .80-1.00 
       Number of Visits to the TDC 1.07*** 1.04-1.10 
Hosmer-Lemeshow goodness-of-fit: χ2= 3.45 (DF=8),  p=.903 
Conclusions 
 
• The Tobacco Dependence Clinic provides an innovative model 
of tailored tobacco dependence treatment which combines 
behavioural counselling with no-cost pharmacotherapy for 
individuals with a history of substance use and/or psychiatric 
disorders for up to 6 months. 
 
• With intensive tobacco dependence treatment provided within 
Mental Health and Addictions services, individuals with a 
history of substance use and/or psychiatric disorders are able 
to achieve smoking abstinence. 
 
 
 

